The elucidation of the mechanisms that regulate PLSCR1 expression, along with the identification of the signaling pathways in which PLSCR1 is involved, may lead to the development of future pharmacological strategies aimed at targeting this factor in cancer, viral infections, allergy and autoimmunity, and possibly other conditions. This evidence concerns the gene PLSCR1 and viral infectious disease.